May 23, 2022 | Drug Costs, Featured, Podcast
On this episode of the podcast, Terry and Bob discuss a new effort by entrepreneur Mark Cuban to deliver less expensive medications to patients. They also explain the ongoing baby formula shortage plaguing the country and point out how the industry’s...
Read more
May 17, 2022 | Featured, Health Insurance, Podcast
On this episode of the podcast, Terry and Bob discuss health access challenges facing patients with rare diseases on employer health plans. They point out new data on drug rebates showing no relationship between the size of rebates and drug price savings. And they...
Read more
May 16, 2022 | Featured, Letters Submitted
We appreciate the work of the Senate Committee on Health, Education, Labor, and Pensions (HELP) in reauthorizing the Food and Drug Administration’s (FDA) user fee programs for generic drugs (GDUFA). The improvements in GDUFA III will speed patient access to safe,...
Read more
May 13, 2022 | Featured, Health Policy
Surabhi Dangi-Garimella, Ph.D. Despite biosimilars being around for a while, utilization in the U.S. has not caught on. Several studies have shown the cost benefit of replacing originator or reference products with biosimilars; however, contracts between drug...
Read more
May 11, 2022 | Actions, Featured, Featured Action, Pharmacy Benefit Managers
Urge the FTC to study the perverse practices of Pharmacy Benefit Managers (PBMs) On February 24, the Federal Trade Commission (FTC) issued a solicitation for comment regarding Pharmacy Benefit Managers (PBMs) and the impact PBMs have on patients, among others. You can...
Read more
May 9, 2022 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the latest medical research into ALS in conjunction with ALS Awareness Month. Dr. Sharon Hesterlee, the Chief Research Officer at the Muscular Dystrophy Association, joins the show to give the big picture on ALS...
Read more
